By Counterforce Health Team in Kymriah (tisagenlecleucel) —

Work With Your Doctor to Get Kymriah (tisagenlecleucel) Covered by Humana in California: Complete Guide

Answer Box: Getting Kymriah Covered by Humana in California

Kymriah (tisagenlecleucel) requires prior authorization from Humana Medicare Advantage plans in California. The fastest path to approval: (1) Confirm treatment at a certified CAR-T center like City of Hope or Stanford, (2) Have your oncologist submit a complete prior authorization with CD19-positive lab results and treatment history, and (3) If denied, file an internal appeal within 65 days. Start today by calling Humana at the number on your member card to request prior authorization forms and confirm your chosen facility is in-network.

Table of Contents

  1. Set Your Goal: Understanding Approval Requirements
  2. Visit Preparation: Building Your Medical Case
  3. Evidence Kit: Documents You'll Need
  4. Letter of Medical Necessity Structure
  5. Peer-to-Peer Review Support
  6. After-Visit Documentation
  7. Respectful Persistence and Follow-Up
  8. Appeals Process in California
  9. Common Denial Reasons and Solutions
  10. Frequently Asked Questions

Set Your Goal: Understanding Approval Requirements

Your partnership with your doctor starts with understanding exactly what Humana needs to approve Kymriah. This CAR-T cell therapy costs approximately $373,000-$475,000, making prior authorization mandatory for all Humana plans.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It
Prior Authorization Mandatory pre-approval Humana Prior Authorization Portal
Certified Treatment Center Must be FDA-approved CAR-T facility Humana Transplant Network
CD19-Positive Disease Lab confirmation required Your oncologist's pathology reports
Failed Prior Therapies ≥2 lines for DLBCL, ≥1 for ALL Treatment records from your medical team
Age Limits Up to 25 for ALL, adults for DLBCL FDA labeling requirements

California-Certified CAR-T Centers in Humana's Network

Based on current network information, these facilities can administer Kymriah:

  • City of Hope National Medical Center (Duarte)
  • Stanford Medical Center (Stanford)
  • UCSF Medical Center (San Francisco)
  • UCLA Medical Center (Los Angeles)
  • UC San Diego Medical Center (San Diego)
  • UC Davis Medical Center (Sacramento)
  • Children's Hospital Los Angeles
  • Rady Children's Hospital (San Diego)
Note: Always verify current network status by calling HealthCheck360 at 844-462-7812 before scheduling any consultations.

Visit Preparation: Building Your Medical Case

Come to your appointment prepared to help your doctor build the strongest possible case for Kymriah approval.

Your Symptom and Treatment Timeline

Prepare a chronological summary including:

  • Diagnosis date and initial staging
  • Each treatment received (chemotherapy regimens, targeted therapies, stem cell transplant)
  • Response to each treatment (complete response, partial response, progression)
  • Side effects that led to treatment discontinuation
  • Current disease status and symptoms affecting daily life

Functional Impact Documentation

Your doctor needs to understand how your condition affects your quality of life:

  • Energy levels and fatigue patterns
  • Ability to work or attend school
  • Physical limitations
  • Hospitalizations in the past 6 months
  • Emergency department visits

Evidence Kit: Documents You'll Need

Work with your medical team to gather these essential documents:

Laboratory and Diagnostic Evidence

  • CD19 expression testing (flow cytometry or immunohistochemistry)
  • Recent imaging (PET/CT, bone marrow biopsy results)
  • Complete blood counts and chemistry panels
  • Molecular testing results (cytogenetics, next-generation sequencing)

Treatment History Summary

  • Discharge summaries from previous hospitalizations
  • Infusion records showing dates and doses of prior therapies
  • Response assessments after each treatment line
  • Documentation of treatment failures or intolerances

Insurance Documentation

  • Current Humana member ID card
  • Summary of Benefits and Coverage (SBC)
  • Any previous denial letters
  • Explanation of Benefits (EOB) statements

Letter of Medical Necessity Structure

Your oncologist will need to write a comprehensive letter supporting your Kymriah request. Here's what should be included:

Essential Components

1. Patient Demographics and Diagnosis

  • Full name, date of birth, member ID
  • Specific diagnosis with ICD-10 codes
  • Date of initial diagnosis and current disease status

2. CD19 Expression Documentation

  • Laboratory confirmation of CD19-positive disease
  • Date of most recent testing
  • Percentage of CD19-positive cells if available

3. Treatment History

  • Chronological list of all prior therapies
  • Dates of treatment and duration
  • Response to each treatment (CR, PR, stable disease, progression)
  • Reasons for treatment discontinuation

4. Clinical Rationale for Kymriah

  • Why Kymriah is medically necessary now
  • Why other treatments are not appropriate
  • Expected benefits and treatment goals
  • Urgency of treatment (if applicable)

5. Supporting Guidelines and Literature

  • FDA approval for your specific indication
  • NCCN Guidelines recommendations
  • Relevant clinical trial data
  • Peer-reviewed studies supporting use
Clinician Tip: Reference the specific NCCN guideline version and page number. For DLBCL, cite the current B-Cell Lymphomas guidelines; for ALL, reference the Acute Lymphoblastic Leukemia guidelines.

Peer-to-Peer Review Support

If Humana initially denies your request, your doctor can request a peer-to-peer (P2P) review with a Humana medical director.

How to Support Your Doctor's P2P Call

Offer Scheduling Flexibility

  • Provide multiple time windows when you're available for questions
  • Ensure your doctor has your current contact information
  • Be prepared to join the call if requested

Prepare a Concise Case Summary Help your doctor prepare a 2-3 minute summary covering:

  • Your age and specific diagnosis
  • Number of prior treatment lines and failures
  • Current performance status
  • Why delay would be harmful
  • CD19 positivity confirmation

P2P Call Script for Your Doctor

"This is Dr. [Name] calling about [Patient Name], member ID [Number]. This 24-year-old patient has relapsed B-cell precursor ALL after failing two lines of therapy. Recent bone marrow biopsy confirms 85% CD19-positive blasts. The patient's performance status is declining, and delay in CAR-T therapy could result in disease progression beyond salvage. We have confirmed availability at [Center Name], an FDA-certified CAR-T facility in your network."

After-Visit Documentation

Maintain organized records of all communications and submissions.

What to Save

  • Copy of the prior authorization request with submission date
  • Confirmation numbers from phone calls or online submissions
  • Names and titles of Humana representatives you speak with
  • Reference numbers for peer-to-peer review requests
  • Copies of all supporting documents sent to Humana

Portal Communication Best Practices

When messaging through Humana's member portal:

  • Use clear subject lines: "Kymriah Prior Authorization - Member ID [Number]"
  • Include relevant dates and reference numbers
  • Attach documents in PDF format when possible
  • Keep messages professional and factual

Respectful Persistence and Follow-Up

Appropriate follow-up timing and escalation strategies help move your case forward without damaging relationships.

Follow-Up Schedule

  • Week 1: Confirm receipt of prior authorization
  • Week 2: Check on review status if no response
  • Week 3: Request expedited review if medically urgent
  • Week 4: Escalate to supervisor if standard timeline exceeded

Polite Escalation Script

"Hello, this is [Your Name], member ID [Number]. I submitted a prior authorization for Kymriah three weeks ago (reference number [X]). My oncologist indicates this treatment is time-sensitive due to my condition. Can you please connect me with a supervisor to discuss expediting this review?"

Appeals Process in California

California provides robust appeal rights through both Humana's internal process and the state's Independent Medical Review (IMR) system.

Step-by-Step Appeals Process

1. Internal Appeal with Humana (Required First Step)

  • Timeline: Must file within 65 days of denial
  • Decision timeframe: 30 days for standard, 72 hours for expedited
  • How to file: Online portal, phone, or mail
  • Required documents: Denial letter, supporting medical records, physician statement

2. California Independent Medical Review (IMR)

  • When to use: After Humana upholds their denial
  • Timeline: File within 6 months of final internal denial
  • Decision timeframe: 45 days standard, 7 days expedited
  • How to file: DMHC website or call 888-466-2219
  • Success rate: 30-60% overturn rate for specialty oncology drugs

Required Forms and Contacts

Humana Appeals

  • Submit via member portal or mail to address on denial letter
  • Include form from denial notice
  • Attach all supporting medical documentation

California IMR

Important: California's IMR decisions are binding on Humana. If the independent medical reviewer determines Kymriah is medically necessary, Humana must approve coverage.

Counterforce Health helps patients navigate complex insurance appeals by analyzing denial letters and crafting evidence-backed responses. Their platform identifies specific denial reasons and develops targeted rebuttals using peer-reviewed literature and payer-specific requirements, potentially improving your chances of approval.

Common Denial Reasons and Solutions

Denial Reason How to Respond Documents Needed
"Not medically necessary" Provide NCCN guidelines and clinical evidence Current guidelines, peer-reviewed studies
"Experimental/investigational" Reference FDA approval and clinical data FDA labeling, pivotal trial results
"Step therapy not completed" Document failed prior therapies Treatment records, response assessments
"Not at certified facility" Confirm center certification Facility accreditation documents
"CD19 status unclear" Provide recent lab confirmation Flow cytometry or IHC results

Frequently Asked Questions

How long does Humana prior authorization take for Kymriah? Standard prior authorization decisions are made within 30 days. Expedited reviews for urgent cases are completed within 72 hours.

What if Kymriah is not on Humana's formulary? CAR-T therapies like Kymriah typically require case-by-case medical review rather than standard formulary placement. Focus on medical necessity rather than formulary status.

Can I request an expedited appeal? Yes, if waiting for a standard decision could seriously jeopardize your health. Your doctor must provide documentation supporting the urgency.

What if my preferred CAR-T center is out of network? Humana may approve single-case agreements for out-of-network care if no in-network certified facility is available within a reasonable distance.

Does step therapy apply if I received treatment outside California? Treatment records from any location count toward step therapy requirements. Ensure your doctor includes all prior therapies in the authorization request.

How much will Kymriah cost me out-of-pocket? Costs depend on your specific Humana plan. Medicare Advantage plans typically have annual out-of-pocket maximums. Check with Novartis about patient assistance programs.

What happens if both internal appeals and IMR are denied? You can pursue federal court review, though this is rare. Consider seeking a second opinion or exploring clinical trials as alternatives.

Can I get help preparing my appeal? Yes, California provides free assistance through the DMHC Help Center (888-466-2219). Legal aid organizations and patient advocacy groups can also provide support.

Sources and Further Reading

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider regarding your specific medical condition and treatment options. Insurance coverage decisions depend on individual circumstances and plan details.

For additional support navigating insurance appeals and prior authorizations, Counterforce Health provides specialized assistance in turning denials into successful approvals through evidence-based appeal strategies.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.